diethyl (2-hydroxy-2-(4-((5-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)methyl)-1H-1,2,3-triazol-1-yl)ethyl)phosphonate

ID: ALA5287455

Chembl Id: CHEMBL5287455

Max Phase: Preclinical

Molecular Formula: C21H22N5O8P

Molecular Weight: 503.41

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOP(=O)(CC(O)n1cc(CN2C(=O)c3cccc4cc([N+](=O)[O-])cc(c34)C2=O)nn1)OCC

Standard InChI:  InChI=1S/C21H22N5O8P/c1-3-33-35(32,34-4-2)12-18(27)25-11-14(22-23-25)10-24-20(28)16-7-5-6-13-8-15(26(30)31)9-17(19(13)16)21(24)29/h5-9,11,18,27H,3-4,10,12H2,1-2H3

Standard InChI Key:  TUAPXPQRDLGOMJ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5287455

    ---

Associated Targets(Human)

CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMEC-1 (426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 503.41Molecular Weight (Monoisotopic): 503.1206AlogP: 2.89#Rotatable Bonds: 10
Polar Surface Area: 166.99Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.37CX Basic pKa: CX LogP: 1.41CX LogD: 1.41
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.19Np Likeness Score: -0.98

References

1. Tomczyk MD, Walczak KZ..  (2018)  l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017.,  159  [PMID:30312931] [10.1016/j.ejmech.2018.09.055]

Source